Advertisement

Topics

Eli Lilly Reports Japan Marketing Approval For Olumiant

08:23 EDT 3 Jul 2017 | FinanzNachrichten

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) and Incyte Corp. (INCY) announced the Japan's Ministry of Health, Labor and Welfare granted marketing approval for Olumiant (baricitinib) 2-mg ...

Original Article: Eli Lilly Reports Japan Marketing Approval For Olumiant

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly Reports Japan Marketing Approval For Olumiant"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...